We recently published Big Winners: 10 Stocks Refusing to take a Holiday. Novo Nordisk A/S (NYSE:NVO) is one of the last week's best performers. Novo Nordisk grew its share prices by 8.96 percent ...

The genetic basis of autism is beginning to come to light. De novo mutations in gene copy number may have a big role. Autism is a disorder of communication and behavior that usually includes language ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...

Novo Nordisk can reach MASH patients with the recent FDA decision expanding approval of its GLP-1 drug Wegovy to the treatment of moderate-to-advanced cases of the fatty liver disease. Now it’s ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Mumbai: Less than a month after Ozempic maker Novo Nordisk announced it is cutting its global workforce as part of a restructuring plan, the layoffs have hit Indian employees in Bengaluru. Junior- to ...

Bengaluru: German software giant SAP and Danish pharma major Novo Nordisk are reducing their global workforce, a move that will also impact employees in India. Novo announced plans to cut about 9,000 ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...

Novo Nordisk’s stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several disappointing trial results. However, analysts remain optimistic about the shares, ...

Europe’s largest pharmaceutical firm, Novo Nordisk, saw its stocks tumble 27% in March, marking their worst monthly performance since July 2002. As of market close on 31 March, the Danish firm’s share ...